z-logo
Premium
Homozygous inactivation of WTI in a Wilms' tumor associated with the WAGR syndrome
Author(s) -
Gessler Manfred,
König Anja,
Moore Jay,
Qualman Steven,
Arden Karen,
Cavenee Webster,
Bruns Gail
Publication year - 1993
Publication title -
genes, chromosomes and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.754
H-Index - 119
eISSN - 1098-2264
pISSN - 1045-2257
DOI - 10.1002/gcc.2870070304
Subject(s) - wilms' tumor , cancer research , medicine , wilms tumour , oncology
Wilms' tumor is a childhood nephroblastoma that is postulated to arise through the inactivation of a tumor suppressor gene by a two‐hit mechanism. A candidate 11p13 Wilms' tumor gene, WTI , has been cloned and shown to encode a zinc finger protein. Patients with the WAGR syndrome (Wilms' tumor, aniridia, genitourinary abnormalities, and mental retardation) have a high risk of developing Wilms' tumor and they carry constitutional deletions of one chromosome 11 allele encompassing the WTI gene. Analysis of the remaining WTI allele in a Wilms' tumor from a WAGR patient revealed the deletion of a single nucleotide in exon 7. This mutation likely played a key role in tumor formation, as it prevents translation of the DNA‐binding zinc finger domain that is essential for the function of the WTI polypeptide as a transcriptional regulator. © 1993 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom